Pharmaceutical Water Market Report 2026

The pharmaceutical water market size has grown rapidly in recent years. It will grow from $41.69 billion in 2025 to $46.16 billion in 2026 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to limited availability of pharmaceutical-grade water, reliance on conventional purification systems, growing pharmaceutical manufacturing activities, increasing regulatory requirements for water quality, expansion of research laboratories and academic facilities.

The pharmaceutical water market size is expected to see rapid growth in the next few years. It will grow to $68.68 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to adoption of advanced water purification technologies, expansion of biopharmaceutical production, increasing demand for sterile water in injections and inhalation products, growing investments in pharmaceutical R&D, rising focus on sustainable water treatment and recycling practices. Major trends in the forecast period include rising demand for highly purified and sterile water in pharmaceutical manufacturing, expansion of cell culture and bioprocessing applications, increasing adoption of water for injection and inhalation products, focus on regulatory compliance and quality assurance in water systems, growth in contract research and manufacturing organizations (cros) using specialized water.

The growing demand from the biotechnology industry is expected to drive the expansion of the pharmaceutical water market in the coming years. Biotechnology is a scientific field that focuses on applying biological processes, organisms, or systems to develop products and technologies that benefit society. The increasing requirement for pharmaceutical water within the biotechnology sector is driven by innovations in genetic engineering, advancements in research methodologies, and the rising production of biopharmaceuticals. Pharmaceutical water plays a critical role in biotechnology by delivering the required levels of purity and quality for research, development, and manufacturing activities, ensuring that biotech products remain safe, effective, and compliant with regulatory standards. For example, in January 2025, according to the BioIndustry Association (BIA), a UK-based trade association, the UK biotech sector raised £3.5 billion ($4.04 billion) in 2024, representing a 94% increase compared to the previous year. As a result, the growing demand from the biotechnology industry is contributing to the growth of the pharmaceutical water market.

Major companies operating in the pharmaceutical water market are concentrating on the development of innovative solutions, such as Water for Injection (WFI), to enhance the efficiency and quality of water purification processes. Water for Injection is a highly purified form of pharmaceutical water that meets stringent quality standards and is specifically intended for the preparation of injectable drugs. For instance, in June 2024, Asahi Kasei Corporation, a Japan-based chemical company, introduced a new membrane-based system for producing Water for Injection, which is essential for injection preparation. The system uses a Microza hollow-fiber membrane and provides a more energy-efficient and environmentally friendly alternative to conventional distillation techniques. This approach streamlines the production process by removing the need for steam cooling and condensation, making it simpler and more efficient.

In May 2023, Xylem Inc., a US-based water technology company, acquired Evoqua Water Technologies Corp. for an undisclosed amount. This acquisition is intended to strengthen Xylem’s position within the water technology market, broaden its product portfolio, and support innovation in water management solutions. Evoqua Water Technologies Corp. is a US-based company that specializes in delivering advanced water treatment solutions designed specifically for pharmaceutical industry applications.

Major companies operating in the pharmaceutical water market are Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Ecolab Inc., Baxter International Inc., B. Braun Melsungen AG, Xylem Inc., Sartorius AG, Pentair PLC, Waters Corporation, Pall Corporation, Veolia Water Solutions And Technologies, Hikma Pharmaceuticals PLC, Hach Company, BWT AG, Evoqua Water Technologies, Kinetico Incorporated, Nexus Pharmaceuticals, Aqua-Chem Inc., FujiFilm Irvine Scientific Inc., Medi-Pure Incorporated, Lenntech B.V.

North America was the largest region in the pharmaceutical water market in 2025. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the pharmaceutical water market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharmaceutical water market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the pharmaceutical water market by increasing the cost of imported water purification equipment, reverse osmosis systems, and filtration components. Segments such as highly purified water and water for injection are most affected, with North America, Europe, and Asia-Pacific regions like China and India experiencing the highest impact. While tariffs have increased operational costs and slowed equipment procurement, they have also encouraged local manufacturing, investment in domestic water treatment technologies, and development of cost-efficient pharmaceutical water solutions.

The pharmaceutical water market research report is one of a series of new reports that provides pharmaceutical water market statistics, including pharmaceutical water industry global market size, regional shares, competitors with a pharmaceutical water market share, detailed pharmaceutical water market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical water industry. This pharmaceutical water market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pharmaceutical water is water that meets stringent quality standards and is used in the production, processing, and formulation of pharmaceutical products and medical applications. This water is used in various stages of pharmaceutical manufacturing, including in the preparation of drug products, equipment cleaning, and ingredient formulation.

The main product types of pharmaceutical water are highly purified water, water for injection, water for inhalation, deionized water, distilled water, others. Highly purified water is water that meets the standards for microbial and chemical purity, often used when water of high microbiological quality is needed. These are used in various applications such as drug formulation, cleaning and purification, cell culture production, equipment cleaning, buffers and solutions, and others and also by various end users such as pharmaceutical and biotechnology companies, contract research and manufacturing organizations, academics and research laboratories, hospitals and healthcare facilities, diagnostic laboratories, and others.

The pharmaceutical water market consist of revenues earned by entities by providing repair and consulting services, installation and setup of water purification systems, and maintenance and servicing of water systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical water market also includes sales of spare equipment, reverse osmosis units, distillation systems, and deionization systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.